Schizandrin

Schizandrin is a dibenzocyclooctadiene lignan found primarily in Schisandra chinensis berries. It demonstrates hepatoprotective effects by modulating antioxidant enzyme systems and reducing inflammatory cytokine production.

Origin & History

Schizandrin is a polycyclic lignan compound extracted from the fruit of Schisandra chinensis (Turcz.) Baill., a traditional medicinal plant native to East Asia. The compound exists in multiple isomeric forms (schizandrin A, B, and C), each with distinct pharmacological properties.

Historical & Cultural Context

Schisandra chinensis has been used in Traditional Chinese Medicine (TCM) for centuries and is classified as a functional food. Modern research has validated its traditional use for liver diseases, with schizandrin exhibiting sedative, hypnotic, anti-aging, antioxidant, and immunomodulatory properties.

Health Benefits

• May support liver health by reducing inflammation and oxidative stress (preliminary animal evidence, PMID: 33588680)
• May help protect against kidney fibrosis through TGF-β pathway regulation (preliminary zebrafish evidence, PMID: 40500382)
• Shows potential anti-cancer properties in colon cancer models (preliminary mouse evidence, PMID: 38481680)
• May improve memory function in neurodegenerative conditions (preliminary mouse evidence, PMID: 22829961)
• Demonstrates anti-inflammatory effects through multiple cellular pathways (preliminary cell culture evidence)

How It Works

Schizandrin activates the Nrf2-ARE signaling pathway, enhancing expression of antioxidant enzymes including glutathione peroxidase and superoxide dismutase. It inhibits NF-κB pathway activation, reducing pro-inflammatory cytokines like TNF-α and IL-6. The compound also modulates TGF-β signaling to prevent fibrotic tissue formation in organs.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses of schizandrin were found in the research. All available evidence comes from preclinical studies using animal models (mice and zebrafish) and cell culture systems (PMIDs: 33588680, 40500382, 38481680, 22829961).

Clinical Summary

Current research on schizandrin is primarily limited to animal and in vitro studies. In rodent hepatotoxicity models, schizandrin administration reduced liver enzyme markers and inflammatory cytokines. Zebrafish studies showed protection against kidney fibrosis through TGF-β pathway regulation. Human clinical trials investigating schizandrin's therapeutic effects are lacking, making efficacy claims preliminary.

Nutritional Profile

Schizandrin (also known as Schisandrin A) is a dibenzocyclooctadiene lignan, not a food or nutrient per se, so it lacks a conventional macronutrient profile (no significant calories, protein, fat, carbohydrates, or fiber). It is one of the principal bioactive lignans found in Schisandra chinensis (five-flavor berry) fruit, typically present at approximately 0.1–0.5% w/w of dried fruit depending on cultivar and extraction method. Key details: • Molecular formula: C₂₄H₃₂O₇; molecular weight: ~432.5 g/mol. • It belongs to a family of related lignans including schisandrin B (γ-schisandrin), schisandrin C, schisandrol A, schisandrol B, gomisin A, gomisin N, and deoxyschisandrin, all sharing the dibenzocyclooctadiene skeleton. • Typical concentrations in standardized Schisandra chinensis extracts range from 2–9% total schisandrins, with schizandrin (schisandrin A) constituting roughly 15–30% of total lignan content. • Bioavailability: Oral bioavailability in rodent models is moderate (estimated ~20–35%), with relatively rapid absorption (Tmax ~1–2 hours in rats). It is lipophilic (LogP ~3.5–4.0), meaning co-administration with dietary fats or lipid-based delivery systems can enhance absorption. It undergoes significant first-pass hepatic metabolism via CYP3A4 and CYP2C enzymes, yielding various hydroxylated and demethylated metabolites. • The compound is not a source of vitamins or minerals. Its pharmacological relevance stems entirely from its lignan structure, which confers antioxidant activity (radical scavenging, estimated ORAC contribution in crude extract), hepatoprotective properties (modulation of phase I/II detoxification enzymes, upregulation of glutathione and superoxide dismutase), anti-inflammatory activity (NF-κB and MAPK pathway modulation), and neuroprotective potential. • In whole Schisandra chinensis dried fruit, co-occurring nutrients include: vitamin C (~3–5 mg/100 g dried fruit), vitamin E (~1–2 mg/100 g), organic acids (citric, malic, tartaric; ~5–10% w/w), trace minerals (potassium, magnesium, iron, zinc in small amounts), essential oils (~1–3% w/w containing sesquiterpenes such as ylangene and chamigrene), and polysaccharides (~2–5% w/w with reported immunomodulatory activity). • Schizandrin itself is commonly encountered in supplement form at doses of 5–30 mg per capsule (as isolated compound) or 250–1000 mg of standardized Schisandra extract providing roughly 15–50 mg total lignans per serving. • Protein binding is high (~85–90% bound to plasma albumin), and the compound distributes preferentially to liver, kidney, and brain tissues, which aligns with its observed organ-specific protective effects. • No established Dietary Reference Intake (DRI) or Recommended Daily Allowance (RDA) exists; dosing is guided by traditional use and preliminary clinical data, typically 5–15 mg/day of pure schizandrin or 500–1500 mg/day of standardized extract.

Preparation & Dosage

Animal studies have used 30 mg/kg administered intragastrically in mice. No human dosing data, standardized extract percentages, or clinical formulations are available. Significant hepatic and intestinal first-pass metabolism limits bioavailability. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Milk thistle, N-acetylcysteine, Alpha-lipoic acid, Curcumin, Glutathione

Safety & Interactions

Safety data for isolated schizandrin supplementation in humans is limited. Traditional use of Schisandra chinensis suggests general tolerability, though individual sensitivity may occur. Potential interactions with cytochrome P450 enzymes could affect drug metabolism. Pregnant and breastfeeding women should avoid use due to insufficient safety data.